Bank Of New York Mellon Corp 10x Genomics, Inc. Transaction History
Bank Of New York Mellon Corp
- $541 Trillion
- Q4 2024
A detailed history of Bank Of New York Mellon Corp transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Bank Of New York Mellon Corp holds 290,031 shares of TXG stock, worth $2.41 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
290,031
Previous 335,368
13.52%
Holding current value
$2.41 Million
Previous $7.57 Billion
45.0%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding TXG
# of Institutions
309Shares Held
95.8MCall Options Held
76.4KPut Options Held
132K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.9MShares$99.1 Million1.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$90.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$53.1 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.5.71MShares$47.4 Million0.92% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.5.36MShares$44.5 Million0.03% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $789M
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...